Topical decongestants in combination therapy of acute respiratory infections in children (a literature review)

Topical decongestants in combination therapy of acute respiratory infections in children (a literature review)

A. B. Мalakhov, I. S. Shatalina, I. A. Dronov, M. A. Malakhov-kapanadze, A. R. Denisova

Acute respiratory infections are a serious public health problem due to very high incidence and a serious economic burden. They account for about 90% of all infectious diseases and 70% of childhood diseases. About ¼ of the total health care costs are associated with the diagnosis and treatment of acute respiratory infections. Though the disease is often moderate and has a good prognosis, it can significantly affect the well-being of children and interfere with their activities of daily living. [1-2]. In most cases (about 95%), acute respiratory infections are caused by a variety of viruses - influenza and parainfluenza, respiratory syncytial, adenovirus, rhinovirus, coronavirus, enterovirus, with the total number of etiological serotypes exceeding180. [1] The significant incidence of acute respiratory infection (ARI) is conditioned by several factors: high susceptibility of children (especially young children), variety of pathogens, as well as air-borne transmission and high contagiousness. [3]

2015

Children, acute respiratory infections, rhinosinusitis, topical nasal decongestants, xylometazoline, дети, острая респираторная вирусная инфекция, риносинусит, топические назальные деконгестанты, ксилометазолин

DOI: 10.21518/2079-701X-2015-14-26-29

Медицинский совет

Remedium Group LLC

Medicine

RU